Amgen vs Sutro Biopharma
Amgen vs Sutro Biopharma, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amgen is on 34/100 and Sutro Biopharma on 40/100.
Where each one leads
Amgen
- agent readiness: 41/100 against 36/100
- domain rating: 80/100 against 44/100
Sutro Biopharma
- our overall score: 40/100 against 34/100
- funding raised: $296M against $40.0M
At a glance
| Measure | Amgen | Sutro Biopharma |
|---|---|---|
| What it is | A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics. | Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Clinical Trials, Antibody-Drug Conjugates |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 1980 | 2003 |
| Headquarters | Thousand Oaks, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Amgen | Sutro Biopharma |
|---|---|---|
| Employees | 39,919 | Not published |
| Total funding | $40.0M | $296M |
| Latest round | IPO | Public Offering |
| LinkedIn followers | 1,697,311 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amgen | Sutro Biopharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 40/100 |
| Traction | 58/100 | 40/100 |
| Team | 70/100 | 30/100 |
| Community | 8/100 | Not published |
| Search visibility | 68/100 | 2/100 |
| Quality | 15/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 80/100 | 44/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Amgen | Sutro Biopharma |
|---|---|---|
| Hosting | AWS | AWS |
| CDN | CloudFront | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4, Segment |
Amgen vs Sutro Biopharma: common questions
Which is better, Amgen or Sutro Biopharma?
On our 0-100 score Sutro Biopharma rates higher (40/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Amgen and Sutro Biopharma compare on the numbers?
Amgen leads on agent readiness (41/100 against 36/100), domain rating (80/100 against 44/100). Sutro Biopharma leads on our overall score (40/100 against 34/100), funding raised ($296M against $40.0M).
Read the full Amgen review and pricing or the Sutro Biopharma review and pricing. You can also browse other Amgen alternatives we track.